 independ prognost factor patient metastat stage prostat cancer zoladex studi group independ prognost factor surviv men treatment metastat prostat cancer part random clinic trial gonadotropin hormon analogu zoladex goserelin acet implant castrat multivari analysi signific predictor presenc absenc bone pain testosteron level serum alkalin phosphatas level perform statu patient factor favor surviv surviv rate patient none factor favor surviv factor signific separ analysi serum testosteron level pretreat serum testosteron level surviv rate patient serum testosteron level nmol/l signific differ surviv patient serum testosteron level nmol/l result import implic design analysi futur clinic trial hormon therapi patient short-term prognosi diseas